Navigation Links
Ripening secrets of the vine revealed

Whether you prefer a Cabernet Sauvignon or a Pinot Noir grape variety, two new research articles published in the online open access journal, BMC Genomics, offer a host of new genetic information on fruit ripening for this economically important fruit crop.

The grapevine's gene expression analysis reveals two distinct molecular and functional phases that correspond with the green and red grape stages. And researchers have reported the first biochemical evidence that reactive oxygen species accumulate during the colour transition. Stefania Pilati and fellow researchers from the IASMA Research Center, San Michele all'Adige, Italy, investigated ripening Pinot Noir grapes (Vitis vinifera L.) to identify fruit ripening genes and investigate seasonal influences. They found a core set of more than 1,400 ripening-specific genes that fluctuated similarly across three growing seasons and a smaller gene group strongly influenced by climatic conditions.

During the green berry (pre-vraison) phase, numerous genes involved in hormonal signalling and transcriptional regulation were modulated, suggesting large-scale cellular metabolism reprogramming. Auxin, ethylene and light played pivotal roles. During the following ripening (post-vraison) phase, genes for cell-wall organization and biogenesis, carbohydrate and secondary metabolisms, and stress response came into play, whereas photosynthesis was strongly repressed. These transcriptional events tally with the processes of berry softening and accumulation of sugar, colour and aroma compounds, which ultimately determine berry and wine quality. At vraison, the intervening point when grapes slow down their growth and change colour, this study highlighted an oxidative burst involving hydrogen peroxide (H2O2), and an extensive modulation of the enzymatic anti-oxidative network.

Meanwhile, Laurent G. Deluc and colleagues from the University of Nevada, Reno and the Boston University School of Medicine, USA, took a closer look at the V. vinifera Cabernet Sauvignon variety, surveying seven different stages of grape berry development. The team mapped pronounced differences throughout development in messenger-RNA (mRNA) expression for genes that play key functional roles in a host of processes. These included organic and amino acid metabolism, photosynthesis, circadian cycles and pathogen resistance.

In particular, the researchers recorded changes associated with transcription factor expression patterns, abscisic acid (ABA) biosynthesis, and calcium signalling genes that identified candidate factors likely to participate in vraison, or aroma compound production, and in pathway regulation and sequestration of flavonoid compounds. Some mRNAs were observed to decrease or increase specifically throughout ripening and sugar metabolism gene expression pattern analysis revealed an alternative and previously uncharacterised pathway for glucose and triose phosphate production invoked from vraison to mature berries.

Despite the grapevine's importance, genetic cues underlying the biochemical and physical changes during berry and flavour development have lain undiscovered - until now. "The large number of regulatory genes we have identified represents a powerful new resource for dissecting the mechanisms of fruit ripening control in non-climacteric plants", Pilati and co-workers say. Meanwhile, the second team say they have identified "a set of previously unknown genes potentially involved in critical steps associated with fruit development that can now be subjected to functional testing".


Contact: Charlotte Webber
BioMed Central

Related biology news :

1. MIT unraveling secrets of red tide
2. Scientists eye secrets of retinal regeneration
3. NMR researchers unlock hydrogens secrets to spot polymorphism in pharmaceuticals
4. Scientists gather in New Zealand to share oceans secrets
5. New study uncovers secrets behind butterfly wing patterns
6. Eat chocolate, drink wine, add fun to life: SLU geriatrician shares secrets of staying young
Post Your Comments:
(Date:6/2/2016)... , June 2, 2016   The Weather Company , ... Watson Ads, an industry-first capability in which consumers will be ... able to ask questions via voice or text and receive ... Marketers have long sought an advertising ... that can be personal, relevant and valuable; and can scale ...
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") announces ... Clean Technology Fund I, LP and Clean Technology Fund ... venture capital funds which together hold approximately 59% of ... as converted basis), that they have entered into an ... in Biorem to TUS Holdings Co. Ltd. ("TUS") ( ...
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf K. ... the faculty of the University of North Carolina Kenan-Flagler Business School ... entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s international efforts, leading ...
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
Breaking Biology Technology: